Search Within

Howard Scher

Formats
  1. Journal Article (626)
  2. Meeting Abstract (463)
  3. Book Section (13)
  4. Conference Paper (11)
  5. Editorial (7)
  6. Review (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Research Letter (2)
Groups
  1. Department of Medicine (1133)
  2. Genitourinary Oncology Service (1133)
  3. Solid Tumor Oncology Division (1133)
  4. GSK Faculty (305)
  5. Sloan Kettering Institute Faculty (249)
  6. Department of Pathology and Laboratory Medicine (241)

More Groups

People
  1. Michael Morris (217)
  2. Susan Slovin (140)
  3. Dana Rathkopf (133)
  4. Daniel Danila (112)
  5. Steven Larson (110)
  6. Victor Reuter (97)

More People

Years
  1. 2025 (11)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (25)
  5. 2021 (19)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (328)
  2. Clinical Cancer Research (85)
  3. Cancer Research (54)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (47)
  5. Journal of Urology (36)
  6. European Urology (35)

More Publications

Publishers
  1. American Society of Clinical Oncology (335)
  2. American Association for Cancer Research (197)
  3. Elsevier Science, Inc. (119)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (58)
  6. Oxford University Press (47)

More Publishers

Results (1133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive gene expression analysis of metastatic prostate cancer reveals distinct transcriptional programs and potential prognostic markers
    Meeting Abstract

    LaTulippe, E.; Smith, A.; Kuo, D.; Chen, L.; Taylor, F.; Pappas, M.; Caicco, J.; Oplanich, S.; Kotsianti, A.; Scher, H.; more...
    Laboratory Investigation (2002)

    Fulltext@MSK | Save
  • PET-based radiation dosimetry in man of F-18-fluorodihydrotestosterone (FDHT), a new radiotracer for imaging prostate cancer
    Meeting Abstract

    Zanzonico, P.; Finn, R.; Pentlow, K. S.; Erdi, Y.; Beattie, B.; Humm, J.; Akhurst, T.; Squire, O.; Morris, M.; Scher, H.; more...
    Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save
  • Ansamycins inactivate AKT and enhances the anti-tumor effects of paclitaxel
    Meeting Abstract

    Solit, D.; Basso, A.; Munster, P.; Scher, H.; Rosen, N.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
    Meeting Abstract

    Kelly, W.; O'connor, O.; Richon, V. M.; Tong, W.; Rao, T. D.; Chiao, J.; O'Brien, J. P.; Rifkind, R. A.; Marks, P. A.; Scher, H. I.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Clinical experience of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in heavily pre-treated patients with aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
    Meeting Abstract

    O'Connor, O. A.; Richon, V.; Moskowitz, C. H.; Zelenetz, A. D.; Macgregor-Cortelli, B.; Curly, T.; Richardson, S.; Tong, W.; Rifkind, R.; Marks, P.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET
    Journal Article

    Etchebehere, E. C. S. C.; Macapinlac, H. A.; Gonen, M.; Humm, J.; Yeung, H. W. D.; Akhurst, T.; Scher, H. I.; Larson, S. M.
    Quarterly Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save
  • Combined (18)F-FDG and (11)C-methionine PET scans in patients with newly progressive metastatic prostate cancer
    Journal Article

    Nunez, R.; Macapinlac, H. A.; Yeung, H. W. D.; Akhurst, T.; Cai, S. D.; Osman, I.; Gonen, M.; Riedel, E.; Scher, H. I.; Larson, S. M.
    Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save
  • Prostate-specific antigen as a marker of disease activity in prostate cancer
    Journal Article

    Partin, A. W.; Hanks, G. E.; Klein, E. A.; Moul, J. W.; Nelson, W. G.; Scher, H. I.
    Oncology (Norwalk) (2002)

    Fulltext@MSK | Save
  • Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer
    Journal Article

    Fox, W. D.; Higgins, B.; Maiese, K. M.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H. I.; Agus, D. B.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Editorial: States and state transitions are all that really matter
    Journal Article

    Scher, H. I.; Kelly, W. K.
    Journal of Urology (2002)

    Fulltext@MSK | Save